Lupin Strikes Deal In Suit Over Generic Lunesta

Law360, New York (January 3, 2011, 4:11 PM EST) -- Lupin Ltd. on Monday announced that it had reached a settlement with Sunovion Pharmaceuticals Inc. in a lawsuit over a generic version of the sleep aid Lunesta.

Under the settlement, Lupin and its subsidiary, Lupin Pharmaceuticals Inc., would be able to sell a generic version of Lunesta by the end of November 2013, approximately two months before the expiration of one of the patents-in-suit, 6,444,673.

If Sunovion receives six months of additional pediatric exclusivity for Lunesta, the licensing agreement would go into effect at the end...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.